DNA hydrogels are biocompatible drug delivery systems for targeted therapeutic interventions. Conventional DNA hydrogels, formed with many DNA nanostructure units, lead to increased preparation costs ...
The global injectable drug delivery devices market size is calculated at USD 565 billion in 2025 and is expected to reach ...
Colorectal cancer (CRC) is one of the most prevalent types of cancer and has a high mortality rate globally. Oral ...
Researchers from Nantong University developed a novel targeted drug delivery system using functionalized pillararenes for multimodal synergistic cancer therapy, combining chemotherapy and photodynamic ...
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery ...
IntroductionNeglected Tropical Diseases (NTDs) remain a significant health burden in tropical and subtropical regions, with limited treatment options ...
The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...
Aveva Drug Delivery systems (A DifGen company), a leader in transdermal drug delivery systems based out of Miramar - Florida is proud to announce the launch of all strengths of its generic Fentanyl ...
From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...
Image Caption: Zeteo Biomedical Introduces CygnusMRTM and CygnusSDXTM Delivery Devices for Nasal Administration of Dry Powder ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...